Summary
Two deaths in Northern Ireland may be connected to weight-loss injections. The Medicines and Healthcare products Regulatory Agency (MHRA) is investigating these cases, which are part of over 500 reports of suspected drug reactions involving GLP-1 medications in the region. These drugs, like Wegovy and Mounjaro, are used for managing weight and treating diabetes.
Key Facts
- Two people in Northern Ireland possibly died after using weight-loss injections.
- These deaths were reported to the MHRA, the UK agency overseeing drug safety.
- The drugs involved are known as Wegovy and Mounjaro, both used for weight management and diabetes treatment.
- The reports include 511 cases of suspected adverse reactions over two years.
- Among the reports, there were six cases of acute pancreatitis.
- About 1.6 million adults in England, Scotland, and Wales used these drugs for weight loss in 2024-2025.
- The MHRA monitors drug safety through a system called the Yellow Card scheme.
- The reports included 317 reactions to Mounjaro, 135 to Wegovy, and 12 to Ozempic.
